WATER IV PCa (AS Sub-study)
NCT07650448
This study is recruiting at 12 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Localized Prostate Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 45 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- PROCEPT BioRobotics
- Last updated on ClinicalTrials.gov
- November 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- University of Southern California · Los Angeles, CA
Florida · 1
- Advanced Research · Delray Beach, FL
Georgia · 1
- Georgia Urology · Atlanta, GA
Idaho · 1
- Mountain View Hospital · Idaho Falls, ID
Illinois · 1
- Endeavor Health · Glenview, IL
Nebraska · 2
- Kearney Urology Center · Kearney, NE
- Adult & Pediatric Urology · Omaha, NE
New York · 1
- Integrated Medical Professionals, PLLC · New York, NY
South Carolina · 1
- MUSC Hollings Cancer Center · Charleston, SC
Texas · 3
- Midtown Urology · Austin, TX
- Urology Austin · Austin, TX
- Urology Clinics of North Texas · Dallas, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.